Company / Shareholders' Equity
PANACEA LIFE SCIENCES HOLDINGS, INC. Shareholders' Equity History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$8.3M
FY2023
5-year range
-$8.3M / $11.9M
FY2019-FY2023
Trend
-286.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PANACEA LIFE SCIENCES HOLDINGS, INC. reports negative total equity of -$8M in FY2023. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$8M in FY2023.
Declined from $7M to -$8M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, shareholders' equity decreased 286.6% year-over-year.
- Peak shareholders' equity was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$8.3M | -286.6% |
| FY2022 | -$2.1M | -130.2% |
| FY2021 | $7.1M | +5.9% |
| FY2020 | $6.7M | -43.8% |
| FY2019 | $11.9M | +448.7% |
| FY2018 | -$3.4M | -54.6% |
| FY2017 | -$2.2M | -247.7% |
| FY2016 | $1.5M | +1707.5% |
| FY2015 | -$93.3K | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026